{"DataElement":{"publicId":"3390015","version":"1","preferredName":"Metastatic Brain Malignant Neoplasm Postoperative Response Type","preferredDefinition":"The Non-RECIST definition of response at a particular time resulting from the pathologic and/or clinical changes that occr as a result  of treatment of a neoplasm from a primary site to the brain.","longName":"Met_Brain_Neo_Pop_Resp_Type","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"3390014","version":"1","preferredName":"Metastatic Brain Malignant Neoplasm Postoperative Response","preferredDefinition":"The pathologic and/or clinical changes that result from treatment of a neoplasm from a primary site to the brain that are frequently found at the grey/white junctions.","longName":"Meta_Brai_Mali_Post_Germ_Resp","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"3390011","version":"1","preferredName":"Metastatic Brain Malignant Neoplasm","preferredDefinition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.:An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium.:A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C14174:C12439:C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic","conceptCode":"C14174","definition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Brain","conceptCode":"C12439","definition":"An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA0AF481-5C92-E0B4-E040-BB89AD433035","latestVersionIndicator":"Yes","beginDate":"2012-02-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2012-02-28","modifiedBy":"ONEDATA","dateModified":"2012-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3390012","version":"1","preferredName":"Postoperative Germinoma Response","preferredDefinition":"After surgery.:The most common type of germ cell tumor affecting the central nervous system.  It is composed of uniform cells with large vesicular nuclei, prominent nucleoli and clear cytoplasm.  Lymphocytic or lymphoplasmacytic infiltrates are usually seen admixed with the tumor cells.  Less frequently giant syncytiotrophoblastic cells are also present.  Germinomas are usually radiosensitive and they have a favorable prognosis.  - 2002:Response; a bodily process occurring due to the effect of some foregoing stimulus or agent.","longName":"C28006:C3753:C25755","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Postoperative","conceptCode":"C28006","definition":"Relating to or occurring during the period immediately following a surgical operation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Germinoma","conceptCode":"C3753","definition":"A malignant germ cell tumor arising in the central nervous system. It is characterized by the presence of primitive, large malignant germ cells and lymphocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Response","conceptCode":"C25755","definition":"Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA0AF481-5CA4-E0B4-E040-BB89AD433035","latestVersionIndicator":"Yes","beginDate":"2012-02-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2012-02-28","modifiedBy":"ONEDATA","dateModified":"2012-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA0AF481-5CB5-E0B4-E040-BB89AD433035","latestVersionIndicator":"Yes","beginDate":"2012-02-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2012-02-28","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":" Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3386139","version":"1","preferredName":"Brain Maligant Neoplasm Response Type","preferredDefinition":"The pathologic and/or clinical changes that result from treatment resulting in a condition or state at a particular time that are not RECIST definitions of response for germinoma tumors.","longName":"Resp_Type","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Mature teratoma","valueDescription":"Mature Teratoma","ValueMeaning":{"publicId":"2838857","version":"1","preferredName":"Mature Teratoma","longName":"2838857","preferredDefinition":"A teratoma which may be cystic; it is composed entirely of well differentiated, adult-type tissues, without evidence of fetal-type tissues.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mature Teratoma","conceptCode":"C9015","definition":"A teratoma which may be cystic; it is composed entirely of well differentiated, adult-type mature tissues, without evidence of fetal-type immature tissues (grade 0 teratoma).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A98887-3A3C-9A11-E040-BB89AD434E3A","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B9BCE668-5BD5-E8A6-E040-BB89AD435075","beginDate":"2012-02-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2012-02-24","modifiedBy":"ONEDATA","dateModified":"2012-02-24","deletedIndicator":"No"},{"value":"Non-viable tumor","valueDescription":"Non-viable tumor","ValueMeaning":{"publicId":"3386140","version":"1","preferredName":"Non-viable tumor","longName":"3386140","preferredDefinition":"Non-viable tumor","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9BCE668-5BE0-E8A6-E040-BB89AD435075","latestVersionIndicator":"Yes","beginDate":"2012-02-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2012-02-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B9BCE668-5BF9-E8A6-E040-BB89AD435075","beginDate":"2012-02-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2012-02-24","modifiedBy":"ONEDATA","dateModified":"2012-02-24","deletedIndicator":"No"},{"value":"Viable tumor","valueDescription":"Viable tumor","ValueMeaning":{"publicId":"3386141","version":"1","preferredName":"Viable tumor","longName":"3386141","preferredDefinition":"Viable tumor","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9BCE668-5C03-E8A6-E040-BB89AD435075","latestVersionIndicator":"Yes","beginDate":"2012-02-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2012-02-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B9BCE668-5C1C-E8A6-E040-BB89AD435075","beginDate":"2012-02-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2012-02-24","modifiedBy":"ONEDATA","dateModified":"2012-02-24","deletedIndicator":"No"},{"value":"Germ Cell Tumor, NOS","valueDescription":"Germ Cell Neoplasm","ValueMeaning":{"publicId":"7580746","version":"1","preferredName":"Germ Cell Neoplasm","longName":"7580746","preferredDefinition":"Gametes, also known as sex cells or germ cells, are the cells that come together during fertilization or conception in organisms that reproduce sexually.  Their genetic complement consists of a single set of unpaired chromosomes.: A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Germ Cell","conceptCode":"C12597","definition":"Gametes, also known as sex cells or germ cells, are the cells that come together during fertilization or conception in organisms that reproduce sexually.  Their genetic complement consists of a single set of unpaired chromosomes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BBA37289-0638-664C-E053-4EBD850AB796","latestVersionIndicator":"Yes","beginDate":"2021-02-18","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-02-18","modifiedBy":"ONEDATA","dateModified":"2021-02-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BBA37289-0651-664C-E053-4EBD850AB796","beginDate":"2021-02-18","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-02-18","modifiedBy":"ONEDATA","dateModified":"2021-02-18","deletedIndicator":"No"},{"value":"Immature Teratoma","valueDescription":"Immature Teratoma","ValueMeaning":{"publicId":"2838862","version":"1","preferredName":"Immature Teratoma","longName":"2838862","preferredDefinition":"A teratoma composed of immature, fetal-type tissues.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immature Teratoma","conceptCode":"C4286","definition":"A teratoma characterized by the presence of an extensive component of immature, fetal-type tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A98887-3AC1-9A11-E040-BB89AD434E3A","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BBA2442B-622B-0F48-E053-4EBD850AFA37","beginDate":"2021-02-18","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-02-18","modifiedBy":"ONEDATA","dateModified":"2021-02-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2503462","version":"1","preferredName":"Response Type","preferredDefinition":"In medicine, an improvement related to treatment.:Type; a subdivision of a particular kind of thing.","longName":"C50995:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Response","conceptCode":"C50995","definition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1A0F51C2-CD5A-6923-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-02","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-08-02","modifiedBy":"ONEDATA","dateModified":"2006-08-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9BCE668-5BB7-E8A6-E040-BB89AD435075","latestVersionIndicator":"Yes","beginDate":"2012-02-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2012-02-24","modifiedBy":"SPRINGERL","dateModified":"2021-03-08","changeDescription":"Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"COG Text 1","type":"Alternate Question Text","description":"Post second-look surgery response for Stratum 2 patients:","url":null,"context":"CTEP"},{"name":"Post second-look surgery resp","type":"Preferred Question Text","description":"Post second-look surgery response:","url":null,"context":"COG"},{"name":"COG CRF 10","type":"Alternate Question Text","description":"Pathology Result:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA0AF481-5CD2-E0B4-E040-BB89AD433035","latestVersionIndicator":"Yes","beginDate":"2012-02-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2012-02-28","modifiedBy":"SPRINGERL","dateModified":"2021-02-18","changeDescription":"Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}